ISIN | IE00BK5H8015 |
---|---|
Valor Number | 49894453 |
Bloomberg Global ID | |
Fund Name | SPDR® STOXX Europe 600 SRI UCITS ETF EUR Unhedged (Acc) |
Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
Fund Provider | State Street Investment Management |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of European equities. |
Peculiarities |
Current Price * | 32.49 EUR | 05.09.2025 |
---|---|---|
Previous Price * | 32.54 EUR | 04.09.2025 |
52 Week High * | 33.61 EUR | 03.03.2025 |
52 Week Low * | 28.37 EUR | 09.04.2025 |
NAV * | 32.49 EUR | 05.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 471,970,957 | |
Unit/Share Assets *** | 471,970,957 | |
Trading Information SIX |
YTD Performance | +6.42% |
31.12.2024 - 05.09.2025
31.12.2024 05.09.2025 |
---|---|---|
YTD Performance (in CHF) | +5.93% |
31.12.2024 - 05.09.2025
31.12.2024 05.09.2025 |
1 month | +2.40% |
05.08.2025 - 05.09.2025
05.08.2025 05.09.2025 |
3 months | -2.39% |
05.06.2025 - 05.09.2025
05.06.2025 05.09.2025 |
6 months | -2.27% |
05.03.2025 - 05.09.2025
05.03.2025 05.09.2025 |
1 year | +3.90% |
05.09.2024 - 05.09.2025
05.09.2024 05.09.2025 |
2 years | +24.89% |
05.09.2023 - 05.09.2025
05.09.2023 05.09.2025 |
3 years | +44.17% |
05.09.2022 - 05.09.2025
05.09.2022 05.09.2025 |
5 years | +69.10% |
07.09.2020 - 05.09.2025
07.09.2020 05.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
ASML Holding NV | 4.63% | |
---|---|---|
SAP SE | 4.38% | |
AstraZeneca PLC | 3.90% | |
Novartis AG Registered Shares | 3.89% | |
Nestle SA | 3.84% | |
Roche Holding AG | 3.61% | |
Novo Nordisk AS Class B | 2.85% | |
Allianz SE | 2.57% | |
Unilever PLC | 2.55% | |
Banco Santander SA | 2.28% | |
Last data update | 31.08.2025 |
TER *** | 0.12% |
---|---|
TER date *** | 31.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.12% |
Ongoing Charges *** | 0.12% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |